---
title: "Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bo... — FDA record D-0647-2024 | Is It on Recall"
description: "Failed Impurities/Degradation Specifications - at 18-month Stability testing"
url: https://isitonrecall.com/recall/fda-drug-d-0647-2024-ibuprofen-tablets-usp-400mg-generic-for-motrin-pkg-size-30-tablets-per-bottle-mfg-dr-reddy-s-laborat/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Lou... — FDA record D-0647-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Aug 8, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
- **Reason**: Failed Impurities/Degradation Specifications - at 18-month Stability testing
- **Classification**: Class II
- **Recalling firm**: Preferred Pharmaceuticals, Inc.
- **Quantity**: 266 bottles
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0647-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0647-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

CA and NV

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [California](https://isitonrecall.com/state/california/)
- [Nevada](https://isitonrecall.com/state/nevada/)

## Dates in the source

- **Report date**: Sep 4, 2024
- **Recall initiation date**: Aug 8, 2024
- **Center classification date**: Aug 26, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0647-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Ibuprofen records](https://isitonrecall.com/drug/ibuprofen/) [Medications records](https://isitonrecall.com/category/medications/) [Preferred Pharmaceuticals, Inc. records](https://isitonrecall.com/brand/preferred-pharmaceuticals-inc/)